{
    "root": "3533d815-748f-9355-e063-6294a90ab2f0",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Tamsulosin Hydrochloride",
    "value": "20250515",
    "ingredients": [
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "METHACRYLIC ACID",
            "code": "1CS02G8656"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "CALCIUM STEARATE",
            "code": "776XM7047L"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "SHELLAC",
            "code": "MB5IUD6JUA"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T"
        },
        {
            "name": "TAMSULOSIN HYDROCHLORIDE",
            "code": "11SV1951MR"
        }
    ],
    "indications": "tamsulosin hydrochloride capsules indicated treatment signs symptoms benign prostatic hyperplasia ( bph ) [ ( 14 ) ] . tamsulosin hydrochloride capsules indicated treatment hypertension .",
    "contraindications": "tamsulosin hydrochloride capsules 0.4 mg daily recommended dose treatment signs symptoms bph . administered approximately one-half hour following meal day . tamsulosin hydrochloride capsules crushed , chewed opened . patients fail respond 0.4 mg dose 2 4 weeks dosing , dose tamsulosin hydrochloride capsules increased 0.8 mg daily . tamsulosin hydrochloride capsules 0.4 mg used combination strong inhibitors cyp3a4 ( e.g . , ketoconazole ) [ ( 5.2 ) ] . tamsulosin hydrochloride capsules discontinued interrupted several days either 0.4 mg 0.8 mg dose , therapy started 0.4 mg once-daily dose .",
    "warningsAndPrecautions": "tamsulosin hydrochloride capsules , usp comprising olive green opaque cap imprinted “ cl 23 `` , orange opaque body imprinted `` 0.4 `` black ink . ndc : 72162-2502-1 : 100 capsules bottle ndc : 72162-2502-5 : 500 capsules bottle store 20° 25°c ( 68° 77°f ) ; excursions permitted 15° 30°c ( 59° 86°f ) [ usp controlled room temperature ] . keep tamsulosin hydrochloride capsules medicines reach children . repackaged/relabeled : bryant ranch prepack , inc. burbank , ca 91504",
    "adverseReactions": "tamsulosin hydrochloride capsules contraindicated patients known hypersensitive tamsulosin hydrochloride component tamsulosin hydrochloride capsules . included skin rash , urticaria , pruritus , angioedema , respiratory symptoms [ ( 6.2 ) ] .",
    "indications_original": "Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH)\n \n  [see Clinical Studies (\n  \n   14)].\n \n  Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension.",
    "contraindications_original": "Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as the dose for the treatment of the signs and symptoms of BPH. It should be administered approximately one-half hour following the same meal each day. Tamsulosin hydrochloride capsules should not be crushed, chewed or opened. \n    For those patients who fail to respond to the 0.4 mg dose after 2 to 4 weeks of dosing, the dose of Tamsulosin hydrochloride capsules can be increased to 0.8 mg once daily. Tamsulosin hydrochloride capsules 0.4 mg should not be used in combination with strong inhibitors of CYP3A4 (e.g., ketoconazole)\n \n  [see Warnings and Precautions (\n  \n   5.2)].\n \n  \n                       If tamsulosin hydrochloride capsules administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once-daily dose.",
    "warningsAndPrecautions_original": "Tamsulosin hydrochloride capsules, USP are comprising of olive green opaque cap imprinted “CL 23\", and orange opaque body imprinted \"0.4\" in black ink.\n                  \n                  NDC: 72162-2502-1: 100 Capsules in a BOTTLE\n                  NDC: 72162-2502-5: 500 Capsules in a BOTTLE\n                  \n                  Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].\n                  Keep tamsulosin hydrochloride capsules and all medicines out of reach of children.\n                  \n                  Repackaged/Relabeled by:\n  \nBryant Ranch Prepack, Inc.\n  \nBurbank, CA 91504",
    "adverseReactions_original": "Tamsulosin hydrochloride capsules are contraindicated in patients known to be hypersensitive to tamsulosin hydrochloride or any component of tamsulosin hydrochloride capsules. Reactions have included skin rash, urticaria, pruritus, angioedema, and respiratory symptoms\n \n  [see Adverse Reactions (\n  \n   6.2)]."
}